Las Vegas, NV -- (SBWIRE) -- 01/10/2014 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks: Federal National Mortgage Assctn Fnni Me(OTCBB:FNMA), MONITISE PLC(OTCMKTS:MONIF), Neutra Corp(OTCMKTS:NTRR), RXi Pharmaceuticals Corp(OTCMKTS:RXII).
Federal National Mortgage Assctn Fnni Me(OTCBB:FNMA) ended loser -1.85% and complete the day at $3.18. The total number of shares changed hands during the day was 17.01 million. After opening at $3.23, the stock hit as high as $3.34. However, it traded between $0.27 and $5.44 over the last twelve months. Federal National Mortgage Association Fannie Mae is a government-sponsored enterprise (GSE) chartered by the United States Congress to support liquidity and stability in the secondary mortgage market, where mortgage-related assets are purchased and sold.
Has FNMA Found The Bottom and Ready To Move Up? Find Out Here
MONITISE PLC(OTCMKTS:MONIF) closed yesterday at $1.27, a +4.10% increase. Around 6.12 million shares were traded, beating an-average trading volume of 2.89 million shares. The company is now valued at around $2.00 billion. Monitise plc, a technology and services company, provides mobile banking, payments, and commerce solutions for financial institutions, payments companies, retailers, mobile network operators, and other service providers in the United Kingdom, the United States, India, and the Asia Pacific.
For How Long MONIF Gloss will Attract Investors? Find out via this report
Neutra Corp(OTCMKTS:NTRR) moved 47.46 percent higher at $0.870 and traded between $0.51 and $1.00 after opening the day at $0.63. Its performance over the last five days remained 156.64%, which stands at 116.9% for a month. Going back further than one month, 1-year performance after recent close was 176.19%.Neutra Corp. is a development-stage company. The Company’s business and registered office is located in Sarasota, Florida. The Company’s intended private label products consists of aging, cognitive support, antioxidants/flavonoids, circulatory support, detoxification support, endocrine support, essential fatty acids, gastrointestinal support, immune support, men’s health, minerals, mood/sleep support, multiples, musculoskeletal support, neurological support, proteins/amino acids, vitamins, women’s health and veterinary products
For How Long NTRR Gloss will Attract Investors? Find out via this report
RXi Pharmaceuticals Corp(OTCMKTS:RXII) shares rose, gaining 19.10 percent to close at $4.49. The stock is up around 57.54% this year and 5656.41% for the last 12 months. Around 376,484 shares changed hands yesterday, higher from an-average trading volume of 95,714 shares. RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNAi platform. Its RNAi product candidate, RXI-109, is in Phase I clinical trial. RXI-109 targets connective tissue growth factor, a key regulatory of fibrosis and scar formation, and is being developed to reduce or inhibit scar formation in the skin following surgery.
Why Should Investors Buy RXII After The Recent Gain? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)